Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
about
Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screeningGenetics and pathogenesis of malignant hyperthermia.Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermiaEnzyme assays in diseases of the heart and skeletal muscle.Ryanodine receptor channelopathies.Molecular tools to elucidate problems in excitation-contraction couplingDangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.Management of malignant hyperthermia: diagnosis and treatment.Myotonia--a different point of viewHistopathological and neuropharmacological aspects of malignant hyperpyrexia.Clinical, electrophysiological and pathological studies on malignant hyperpyrexia.The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigreeCanine malignant hyperthermia: diagnosis of susceptibility in a breeding colonyA family with intussusception and malignant hyperthermiaEffects of ketamine, thiopental sodium and propofol on muscle contractures in rat diaphragm in vitro.Temperature perturbation studies of sarcoplasmic reticulum from malignant hyperthermia pig muscle.Is malignant hyperpyrexia muscle denervated?Calcium-induced calcium release in skeletal muscle.Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis.Hypertrophy of the branchial muscles. A case with unusual features.Biochemical studies on malignant hyperpyrexiaThe work of the Leeds Malignant Hyperpyrexia Unit, 1971-84.Role of ryanodine receptors.Myoglobin: methods and diagnostic uses.Detecting susceptibility to malignant hyperthermia.Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?To fire the train: a second malignant-hyperthermia gene.The cardiovascular effects of dantrolene sodium in dogs.Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.JSA guideline for the management of malignant hyperthermia crisis 2016.C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.Effects of the halothane-sensitivity gene on sarcoplasmic reticulum function.Halothane-sensitivity gene and muscle contractile properties in malignant hyperthermia.The malignant hyperthermia syndrome: an unusual complication of anesthesia.An unusual case of malignant hyperpyrexia. First reported case in a South African negro.Identification of susceptibility to malignant hyperpyrexia.Biochemical basis of malignant hyperpyrexia.A study of the action of caffeine, halothane, potassium chloride and procaine on normal human skeletal muscle.Malignant hyperpyrexia during general anesthesia. Successful management of a case.
P2860
Q33756722-2CFF8840-2773-4227-8F75-4737DF912F7AQ33789806-7FEB9543-C729-482A-BF5C-F5A5B4017996Q33822243-AE03730E-4318-40E7-BE04-1459E1BE92E1Q33899245-80708E55-DC6F-490A-90B8-224018C4FC1CQ33912937-3FABC786-7AF8-409D-9152-77D9C7D19A8CQ34126738-CAD5994D-3661-4296-817B-277930EE07DAQ34291234-BB23AFE0-CB67-4B8F-BE6A-0F0428944480Q34384665-981DD30E-B580-4A5C-9861-EECD9FD7146BQ34421643-C6B6A493-6AF5-4240-B7FC-7116D8A98549Q34769349-20322B8B-B7E3-4CC3-947E-64844139C1BAQ35142630-0CEC66A4-ED2D-49F6-8EC5-DD9263B45025Q35142640-8C3262FD-BCF2-4938-A2ED-8769C63A1381Q35238558-6070A33F-ED55-48F1-8B7A-AF46C110EFC3Q35622468-F24C3A6D-F637-4704-8C99-1AB7A371596BQ35775713-5CD57D2F-B33B-4356-8FC9-C83C70DEAA30Q36029369-D2FD4FAC-4675-44E5-A4C3-53EA4D47855BQ37042059-A8FF6FD5-0E6D-44B7-9594-5A504EF79649Q37055968-4268B7DF-651F-4362-B161-8E0AD5DC8479Q37605472-BF258002-C22C-42C1-AA57-15DCDEABD78AQ37873106-A9CF4C26-47D0-422C-83FB-3DB6F9D6A591Q39308015-B7341EA1-C8DD-4D52-AB9E-1D897CD49EA3Q39382308-46D2593B-EAFB-4950-A535-6D3FD7BCFA94Q39794540-73867D24-8F08-4A0A-92E5-F91DE4B47C07Q40655808-3490650B-C901-4286-BAE1-D0F9E6E4BEDDQ41219412-E45EFC32-0FB6-456D-8411-3AAA838D01ADQ42765692-44E179F6-2AFD-4001-B7F1-255F05A1A2C2Q43086602-AC871CE1-5BE7-45A2-A6F6-8933D4FADAFCQ43104715-BEC900D1-23DF-4BDF-A03A-63723AB83F94Q44844904-2576F825-73D5-4857-8B56-7A7215C68251Q45180154-D119F5B0-CD6A-4F87-B74D-1662A739D25EQ47324823-9F52D53B-3C46-4B9B-8B00-21AC389570F3Q51616443-29AB808F-A042-4E00-B09F-541D60B9D810Q51747824-90744B2F-85B9-4D7F-A38A-644AFA7F23EFQ51747829-36FF6A29-04E4-4844-80D0-5E05B119E403Q52708517-79CB9299-5E0C-43B3-8D57-9DD157B80287Q52717467-8A80469A-9EF8-4F75-980D-4FD1461D8C2AQ52723781-FB45C38D-9ED8-4A7F-9C2F-466757E17790Q52723784-A219D274-AFB6-490E-BFE6-6E8D01C8BE01Q52724147-4D0DEA72-6E71-48D0-83E0-17EE67DF42F4Q52728224-647CCF3D-F8D4-449A-815E-C8CB9585EA76
P2860
Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
1970年论文
@zh
1970年论文
@zh-cn
name
Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
@en
type
label
Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
@en
prefLabel
Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
@en
P2093
P1433
P1476
Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
@en
P2093
P304
P356
10.1016/S0140-6736(70)92069-6
P407
P577
1970-10-01T00:00:00Z